跳至主要内容
临床试验/NL-OMON25505
NL-OMON25505尚未招募不适用

Endoscopic ultrasonography-guided gastroenterostomy versus surgicalgastrojejunostomy for palliation of malignant gastric outlet obstruction

MC Utrecht0 个研究点目标入组 96 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
96

研究概览

简要总结

one

研究设计

研究类型
Interventional

入排标准

入选标准

  • In order to be eligible for this study, a subject must meet all of the following criteria:
  • -Adult patients with symptomatic malignant gastric outlet obstruction, presenting with nausea, vomiting and/or inability to eat;
  • -Gastric Outlet Obstruction Scoring System Score of 0 (no oral intake) or 1 (liquids only);
  • -Obstruction due to irresectable or metastatic malignancy without curative treatment options;
  • -Radiologically or endoscopically confirmed gastric outlet obstruction;
  • -Location of obstruction extending from the pyloric region to the distal duodenum (third part).
  • -Both treatments (SGJ and EUS-GE) are technically and clinically feasible;
  • -Written informed consent.

排除标准

  • -Radiological or clinical suspicion of other strictures or obstructions along the gastrointestinal tract (distal of the ligament of Treitz), with small intestinal dilation/ileus. Note: patients with diffuse dilatation of the intestines should not be excluded;
  • -Cancer extending into the distal region or corpus of the stomach or around the ligament of Treitz. These types may pose a risk of negatively affecting gastrointestinal motility next to causing gastric outlet obstruction.
  • -Duodenal tube feeding is not tolerated, despite adequate position of the tube;
  • -Altered anatomy after previous gastric, periampullary or duodenal surgery;
  • -Previous SGJ as palliative treatment for the same condition;
  • -Inability to undergo surgery or upper endoscopy due to severe comorbidities (including large-volume ascites);
  • -WHO performance score of 4 (in bed 100% of time);
  • -Uncorrectable coagulopathy, defined by INR > 1.5 or platelets < 50 x 109/L;

研究者

发起方
MC Utrecht

相似试验